08:00 , Dec 8, 2014 |  BC Week In Review  |  Financial News

Promethera completes venture financing

Promethera Biosciences S.A. , Mont-Saint-Guibert, Belgium   Business: Gene/Cell therapy, Endocrine/Metabolic, Hepatic   Date completed: 2014-11-24   Type: Venture financing   Raised: €20.3 million ($25.2 million)   Investors: Vesalius Biocapital Partners; Boehringer Ingelheim Venture Fund;...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

ATMI, Pall deal

On Dec. 23, 2013, Pall said it will acquire ATMI's LifeSciences business for $185 million in cash. ATMI expects the deal to close this quarter. Pall, which provides filtration, separation and purification solutions, expects the...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Financial News

Promethera completes venture financing

Promethera Biosciences S.A. , Mont-Saint-Guibert, Belgium   Business: Gene/Cell therapy, Hepatic   Date completed: 3/28/12   Type: Venture financing   Raised: €17 million ($22.5 million)   Investors: Boehringer Ingelheim Venture Fund; venture arm of Shire...
07:00 , Apr 2, 2012 |  BioCentury  |  Finance

Celling the liver

Celling the liver Alain Parthoens of Vesalius Biocapital Partners hopes the Orphan disease focus of adult stem cell company Promethera Biosciences S.A. will help it achieve what another of his stem cell investments has struggled...
00:34 , Mar 29, 2012 |  BC Extra  |  Financial News

Promethera closes series B

Liver disease company Promethera Biosciences S.A. (Mont-Saint-Guibert, Belgium) raised EUR 17 million ($22.5 million) in a series B round and secured a EUR 6.6 million ($8.7 million) government loan from the Walloon region of Belgium....
08:00 , Dec 5, 2011 |  BC Week In Review  |  Company News

ATMI sales and marketing update

ATMI launched its Integrity Xpansion Bioreactor Systems for large scale production of cell cultures. ATMI Inc. (NASDAQ:ATMI), Danbury, Conn.   Business: Biomanufacturing  ...